Title:
A FORMULATION FOR TREATING OPHTHALMIC CONDITIONS
Document Type and Number:
WIPO Patent Application WO/2021/213512
Kind Code:
A1
Abstract:
A pharmaceutical composition for ophthalmic dosing or administration is disclosed, comprising (i) a compound of Formula (I) or an isotopic variant, tautomer, pharmaceutically acceptable salt, solvate, or hydrate thereof; and (ii) at least one pharmaceutically acceptable excipient. The pharmaceutical composition is formulated as a suspension. The composition may be used to treat ophthalmic disorders and diseases caused by abnormal proliferation of angiogenesis.
Inventors:
ZANG GUANGXI (CN)
LI GEN (CN)
LI GEN (CN)
Application Number:
PCT/CN2021/089415
Publication Date:
October 28, 2021
Filing Date:
April 23, 2021
Export Citation:
Assignee:
GUANGZHOU KANGRUI BIOLOGICAL PHARMACEUTICAL TECH CO LTD (CN)
International Classes:
A61K31/506; A61P27/06; A61P27/10; A61P27/12; A61P35/00; A61P37/00
Foreign References:
| US20170119768A1 | 2017-05-04 | |||
| EP2985283A1 | 2016-02-17 |
Other References:
SUN LI, XU YAN, WU MI: "Applications of Suspending Agents in Suspension Eye Drops", HEBEI CHEMICAL ENGINEERING AND INDUSTRY, vol. 32, no. 8, 31 August 2009 (2009-08-31), CN, pages 24 - 26, XP009531652, ISSN: 1003-5095
See also references of EP 4138841A4
See also references of EP 4138841A4
Attorney, Agent or Firm:
AFD CHINA INTELLECTUAL PROPERTY LAW OFFICE (CN)
Download PDF:
Previous Patent: BISPECIFIC ANTIBODIES FOR TREATING CD47-ASSOCIATED DISEASES
Next Patent: Helideck safety net
Next Patent: Helideck safety net